Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Peterse

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
International Journal of Cancer|January 15, 1990
Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-upA M Uyterlinde, J P Baak, N W Schipper, et al.
Nature Genetics|November 6, 2001
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancerJ Jonkers, R Meuwissen, H van der Gulden, et al.
International Journal of Cancer|June 22, 2000
p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-upM Barbareschi, H van Tinteren, F A Mauri, et al.
Journal of Clinical Pathology|February 25, 2006
The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinomaG Cserni, S Bianchi, V Vezzosi, et al.
Breast Cancer Research and Treatment|October 20, 2006
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancerM Kriege, C T M Brekelmans, H Peterse, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Journal of Cancer|January 15, 1990
Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-upA M Uyterlinde, J P Baak, N W Schipper, et al.
Nature Genetics|November 6, 2001
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancerJ Jonkers, R Meuwissen, H van der Gulden, et al.
International Journal of Cancer|June 22, 2000
p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-upM Barbareschi, H van Tinteren, F A Mauri, et al.
Journal of Clinical Pathology|February 25, 2006
The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinomaG Cserni, S Bianchi, V Vezzosi, et al.
Breast Cancer Research and Treatment|October 20, 2006
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancerM Kriege, C T M Brekelmans, H Peterse, et al.
Pageof 2